Aurora Cannabis (TSE:ACB) Price Target Cut to C$6.50 by Analysts at Canaccord Genuity Group

Aurora Cannabis (TSE:ACB) had its price target cut by Canaccord Genuity Group from C$8.00 to C$6.50 in a research note released on Friday morning,BayStreet.CA reports. They currently have a buy rating on the stock.

Separately, TD dropped their price target on shares of Aurora Cannabis to C$8.00 and set a “buy” rating on the stock in a research report on Friday. Three research analysts have rated the stock with a Buy rating, According to MarketBeat, Aurora Cannabis has an average rating of “Buy” and an average price target of C$7.67.

Aurora Cannabis Stock Performance

ACB stock opened at C$4.25 on Friday. The company has a market capitalization of C$251.29 million, a P/E ratio of -2.83 and a beta of 0.17. The company has a 50-day simple moving average of C$4.76 and a 200 day simple moving average of C$5.30. Aurora Cannabis has a fifty-two week low of C$3.77 and a fifty-two week high of C$9.33. The company has a quick ratio of 2.48, a current ratio of 5.94 and a debt-to-equity ratio of 4.66.

Aurora Cannabis (TSE:ACB) last posted its quarterly earnings data on Thursday, June 11th. The company reported C($0.99) earnings per share for the quarter. The company had revenue of C$38.01 million during the quarter. Aurora Cannabis had a negative return on equity of 7.25% and a negative net margin of 12.13%. Sell-side analysts predict that Aurora Cannabis will post -0.22 earnings per share for the current fiscal year.

About Aurora Cannabis

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Aurora, CanniMed, Daily Special, MedReleaf, and San Rafael ’71. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements or cultivation facilities in more than 20 countries.